Ecoclimber
Senior Member
- Messages
- 1,011
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1
Conclusion: Early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and reduced time to recovery following early COVID-19 infection.
THREAD ANALYSIS BY DR ERIC DING:
1) Hopeful—ASTHMA STEROID INHALER—promising trial found early use of inhaled budesonide (usually for asthma) reduced risk of needing urgent medical care & reduced time to #COVID19 recovery by ~1 day! Also treat 8 patient prevent 1 deterioration—amazing!
2) Clinical recovery was 1 day shorter in the budesonide arm compared to the usual care arm (median of 7 days versus 8 days respectively, p=0.007). Proportion of days with a fever and proportion of participants with at least 1 day of fever was lower in the budesonide arm.3) Fewer participants randomised to budesonide had persistent symptoms at day 14 and day 28 compared to participants receiving usual care.
3) Fewer participants randomised to budesonide had persistent symptoms at day 14 and day 28 compared to participants receiving usual care.....
....7) Ultimately preventing urgent care and hospital visits is most critical. And the NUMBER NEEDED TO TREAT was a remarkable value of 8! That means for every 8 people treated with inhaler, 1 person was prevented from deterioration to an urgent-care / hospital visit! Wow
8) The other beauty of this inhaler is that it is (relatively inexpensive) and widely available already on the market. I want to see another study confirming this, but I’m hopeful..
https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1
Conclusion: Early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and reduced time to recovery following early COVID-19 infection.
THREAD ANALYSIS BY DR ERIC DING:
1) Hopeful—ASTHMA STEROID INHALER—promising trial found early use of inhaled budesonide (usually for asthma) reduced risk of needing urgent medical care & reduced time to #COVID19 recovery by ~1 day! Also treat 8 patient prevent 1 deterioration—amazing!
2) Clinical recovery was 1 day shorter in the budesonide arm compared to the usual care arm (median of 7 days versus 8 days respectively, p=0.007). Proportion of days with a fever and proportion of participants with at least 1 day of fever was lower in the budesonide arm.3) Fewer participants randomised to budesonide had persistent symptoms at day 14 and day 28 compared to participants receiving usual care.
3) Fewer participants randomised to budesonide had persistent symptoms at day 14 and day 28 compared to participants receiving usual care.....
....7) Ultimately preventing urgent care and hospital visits is most critical. And the NUMBER NEEDED TO TREAT was a remarkable value of 8! That means for every 8 people treated with inhaler, 1 person was prevented from deterioration to an urgent-care / hospital visit! Wow
8) The other beauty of this inhaler is that it is (relatively inexpensive) and widely available already on the market. I want to see another study confirming this, but I’m hopeful..
Attachments
Last edited: